Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156991610> ?p ?o ?g. }
- W3156991610 endingPage "175628482110066" @default.
- W3156991610 startingPage "175628482110066" @default.
- W3156991610 abstract "Treatment targets of inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn’s disease (CD) have evolved over the last decade. Goals of therapy consisting of symptom control and steroid sparing have shifted to control of disease activity with endoscopic remission being an important endpoint. Unfortunately, this requires ileocolonoscopy, an invasive procedure. Biomarkers [C-reactive protein (CRP) and fecal calprotectin (FCP)] have emerged as surrogates for endoscopic remission and disease activity, but also have limitations. Despite this evolution, we must not lose sight that CD involves transmural inflammation, not fully appreciated with ileocolonoscopy. Therefore, transmural assessment of disease activity by cross-sectional imaging, in particular with magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS), is vital to fully understand disease control. Bowel-wall thickness (BWT) is the cornerstone in assessment of transmural inflammation and BWT normalization, with or without bloodflow normalization, the key element demonstrating resolution of transmural inflammation, namely transmural healing (TH) or transmural remission (TR). In small studies, achievement of TR has been associated with improved long-term clinical outcomes, including reduced hospitalization, surgery, escalation of treatment, and a decrease in clinical relapse over endoscopic remission alone. This review will focus on the existing literature investigating the concept of TR or residual transmural disease and its relation to other existing treatment targets. Current data suggest that TR may be the next logical step in the evolution of treatment targets." @default.
- W3156991610 created "2021-04-26" @default.
- W3156991610 creator A5008149243 @default.
- W3156991610 creator A5028859025 @default.
- W3156991610 creator A5033555498 @default.
- W3156991610 creator A5040878210 @default.
- W3156991610 creator A5063146539 @default.
- W3156991610 date "2021-01-01" @default.
- W3156991610 modified "2023-10-16" @default.
- W3156991610 title "Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives" @default.
- W3156991610 cites W1547943993 @default.
- W3156991610 cites W1879898010 @default.
- W3156991610 cites W194797074 @default.
- W3156991610 cites W1974590956 @default.
- W3156991610 cites W1988974713 @default.
- W3156991610 cites W1994059647 @default.
- W3156991610 cites W2008551220 @default.
- W3156991610 cites W2009331971 @default.
- W3156991610 cites W2009446106 @default.
- W3156991610 cites W2009834367 @default.
- W3156991610 cites W2020581972 @default.
- W3156991610 cites W2022661087 @default.
- W3156991610 cites W2026437676 @default.
- W3156991610 cites W2028456621 @default.
- W3156991610 cites W2029746055 @default.
- W3156991610 cites W2062633963 @default.
- W3156991610 cites W2063513331 @default.
- W3156991610 cites W2069882434 @default.
- W3156991610 cites W2070414885 @default.
- W3156991610 cites W2071662837 @default.
- W3156991610 cites W2084673760 @default.
- W3156991610 cites W2089176308 @default.
- W3156991610 cites W2102567329 @default.
- W3156991610 cites W2104895663 @default.
- W3156991610 cites W2109081158 @default.
- W3156991610 cites W2115655620 @default.
- W3156991610 cites W2122247171 @default.
- W3156991610 cites W2129472148 @default.
- W3156991610 cites W2129859455 @default.
- W3156991610 cites W2149170290 @default.
- W3156991610 cites W2162912444 @default.
- W3156991610 cites W2170466352 @default.
- W3156991610 cites W2171484002 @default.
- W3156991610 cites W2171495193 @default.
- W3156991610 cites W2208369196 @default.
- W3156991610 cites W2323545219 @default.
- W3156991610 cites W2338635256 @default.
- W3156991610 cites W2374675741 @default.
- W3156991610 cites W2411614474 @default.
- W3156991610 cites W2507998237 @default.
- W3156991610 cites W2509528771 @default.
- W3156991610 cites W2512170462 @default.
- W3156991610 cites W2517773231 @default.
- W3156991610 cites W2528277214 @default.
- W3156991610 cites W2551729000 @default.
- W3156991610 cites W2584559593 @default.
- W3156991610 cites W2593078551 @default.
- W3156991610 cites W2593398029 @default.
- W3156991610 cites W2605508996 @default.
- W3156991610 cites W2609858387 @default.
- W3156991610 cites W2613173051 @default.
- W3156991610 cites W2718703999 @default.
- W3156991610 cites W2742407532 @default.
- W3156991610 cites W2760933485 @default.
- W3156991610 cites W2763377217 @default.
- W3156991610 cites W2766046358 @default.
- W3156991610 cites W2784262185 @default.
- W3156991610 cites W2785248466 @default.
- W3156991610 cites W2785800471 @default.
- W3156991610 cites W2787397416 @default.
- W3156991610 cites W2789641974 @default.
- W3156991610 cites W2790232685 @default.
- W3156991610 cites W2790329004 @default.
- W3156991610 cites W2793022594 @default.
- W3156991610 cites W2799517577 @default.
- W3156991610 cites W2802065432 @default.
- W3156991610 cites W2802103542 @default.
- W3156991610 cites W2808694571 @default.
- W3156991610 cites W2879525346 @default.
- W3156991610 cites W2888061430 @default.
- W3156991610 cites W2896388911 @default.
- W3156991610 cites W2906527131 @default.
- W3156991610 cites W2908193720 @default.
- W3156991610 cites W2909069845 @default.
- W3156991610 cites W2910022856 @default.
- W3156991610 cites W2921521904 @default.
- W3156991610 cites W2922514589 @default.
- W3156991610 cites W2942003336 @default.
- W3156991610 cites W2944025959 @default.
- W3156991610 cites W2944101058 @default.
- W3156991610 cites W2947107438 @default.
- W3156991610 cites W2953592136 @default.
- W3156991610 cites W2980144960 @default.
- W3156991610 cites W2992367942 @default.
- W3156991610 cites W2993817877 @default.
- W3156991610 cites W2994024889 @default.
- W3156991610 cites W2996412011 @default.
- W3156991610 cites W2997847526 @default.